MHV infection of the CNS: mechanisms of immune-mediated control.
about
Molecular mechanisms of severe acute respiratory syndrome (SARS)MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic diseaseVirus-specific and bystander CD8 T cells recruited during virus-induced encephalomyelitisExpression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.Pathogenesis of murine coronavirus in the central nervous system.Cell replacement therapies to promote remyelination in a viral model of demyelinationFTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Matrix metalloproteinase expression correlates with virulence following neurotropic mouse hepatitis virus infectionFunctional expression of chemokine receptor CCR5 on CD4(+) T cells during virus-induced central nervous system disease.Kinetics of virus-specific CD8+ -T-cell expansion and trafficking following central nervous system infection.Control of central nervous system viral persistence by neutralizing antibody.Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropismInhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination.Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase LGamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.The chemokine receptor CXCR2 and coronavirus-induced neurologic disease.Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced InterferonGeneration of a protective T-cell response following coronavirus infection of the central nervous system is not dependent on IL-12/23 signaling.Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cellsInsertion of the CXC chemokine ligand 9 (CXCL9) into the mouse hepatitis virus genome results in protection from viral-induced encephalitis and hepatitisEnhanced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunityCXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination.Murine coronavirus neuropathogenesis: determinants of virulence.MicroRNA 155 and viral-induced neuroinflammation.Murine Coronavirus Cell Type Dependent Interaction with the Type I Interferon ResponseCoronavirus MHV-A59 infects the lung and causes severe pneumonia in C57BL/6 mice.Sphingosine-1-phosphate receptor antagonism enhances proliferation and migration of engrafted neural progenitor cells in a model of viral-induced demyelination.DRAK2 regulates memory T cell responses following murine coronavirus infection.NK cell-mediated destruction of influenza A virus-infected peripheral but not central neurones.Anti-viral effector T cell responses and trafficking are not dependent upon DRAK2 signaling following viral infection of the central nervous system.
P2860
Q24799739-69F273E8-7515-4EA9-997E-C206ECC81DEEQ28596130-A1A7A56B-806A-48F3-92DE-811917F36DCFQ33724194-1F24B634-3FD6-411B-8BB7-66EC655F6F39Q33724251-BACD5534-44E4-4B64-987E-A77174C0C1ECQ34018474-8A308CE1-5CE2-4960-9AA5-F91F01F43501Q34039962-1DF933DC-C1B1-48FF-9868-1F633245A6F7Q34056814-DD8EC64B-D802-4D58-87B0-899923A23B1EQ34105944-48BFA65D-341A-4C59-AA41-3CF1C8312DDDQ34193942-7F08B8B2-B024-4DA1-9091-6FBC70D7C01CQ34343357-9DB7EE2E-BBCF-4BC8-81F7-8BB68F7EC25DQ34462248-DA1A4AAF-4950-407A-85A8-35D59663719FQ34471390-3925D87F-0F70-4558-91FB-CA86DDE46370Q34859605-8FEC7400-739F-49FC-9B55-2334AAC1054DQ34861086-5B930E21-C08F-455A-88F8-02825A6EE2B9Q35088074-E9AD736C-97E4-4CBA-895D-31CAE2CEF387Q35176347-605312A7-B9B9-481E-BBE7-9B289B0A79D2Q35543665-1AF7E79C-A6EE-4665-8E16-28B0C5EB0B49Q35809335-7A5C2453-335F-4006-8CC2-D00C20049DBCQ36445241-1C8A3D47-5B21-4333-8E07-6C016D4BF4ACQ36468266-92C4D56B-91E2-433F-8EDD-7E80D8441FA6Q36736634-BA6F602A-65DE-42CB-A164-BA8A1F53ED48Q36944487-2222B70B-6AFC-46C6-B5E7-AACDB73F0401Q36961739-EEB0118B-94EC-4FF9-B6F7-B004128F4160Q37098484-33EB949A-FBBE-429F-B3D4-FCAFEAB262C0Q37260135-9D7B6CE1-A9AF-436F-8BBE-F7D5E4C18F67Q37425437-07507546-E925-409B-A8C1-CECCBDA42E47Q37809054-CA0ADE40-D1CD-4517-BF31-8700DCF11FE8Q39111001-E707D042-9A4F-4ACB-AD3A-FE592ED3AA01Q39512596-6ADF45A7-E10E-40C4-8055-C814A6335C98Q39614017-519B5A60-5501-498A-878B-48DA1C9E2C53Q40966857-3B183CF7-3751-489D-A7ED-B85DF7D0BB91Q43808764-CFA06333-47C1-40C6-AAA3-C703A15698F9Q45405833-39259E76-EE01-46EC-8404-0503AD39C502Q46029798-DCE66EB1-DD04-4A83-898C-57673DFFF571
P2860
MHV infection of the CNS: mechanisms of immune-mediated control.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
MHV infection of the CNS: mechanisms of immune-mediated control.
@ast
MHV infection of the CNS: mechanisms of immune-mediated control.
@en
MHV infection of the CNS: mechanisms of immune-mediated control.
@nl
type
label
MHV infection of the CNS: mechanisms of immune-mediated control.
@ast
MHV infection of the CNS: mechanisms of immune-mediated control.
@en
MHV infection of the CNS: mechanisms of immune-mediated control.
@nl
prefLabel
MHV infection of the CNS: mechanisms of immune-mediated control.
@ast
MHV infection of the CNS: mechanisms of immune-mediated control.
@en
MHV infection of the CNS: mechanisms of immune-mediated control.
@nl
P1433
P1476
MHV infection of the CNS: mechanisms of immune-mediated control
@en
P2093
Stohlman SA
P356
10.1089/08828240151061329
P577
2001-01-01T00:00:00Z